Trust Board meeting in Public: Wednesday 14 November 2018 TB

Size: px
Start display at page:

Download "Trust Board meeting in Public: Wednesday 14 November 2018 TB"

Transcription

1 Trust Board meeting in Public: Wednesday 14 November 20 Title Integrated Performance Report: Month 6 Status History For information. The report provides a summary of the Trust s performance against a range of key performance indicators as agreed by the Trust Board. Board Lead(s) Ms Sara Randall, Acting Director of Clinical Services Key purpose Strategy Assurance Policy Performance Integrated Performance Report M6 Page 1 of 20

2 Executive Summary 1. In September 20, 1,572 patients waited over four hours from arrival to admission, transfer or discharge from OUH s Emergency Departments. 2. The Trust s four-hour wait performance rose 1% to 88.02%, but this was the second month in which the trajectory level agreed with NHS Improvement was not met. 3. Since March, no patient has waited over 12 hours from a decision to admit to admission. 4. On 30 September 20, 9,036 of 52,951 patients on incomplete elective care pathways at OUH were waiting for over weeks % of people awaiting elective care were waiting for less than weeks, a reduction in performance of 1% since August and well below the national 92% standard. 6. Over 52-week waits in Gynaecology remained stable at 158. Another 41 patients were waiting for over 52 weeks for treatment in 13 other specialties. 7. Three cancer waiting time standards were not met in September: the standard for 96% of patients to receive first definitive treatment within 31 days of a decision to treat; for first treatment within 62 days of urgent GP referral; and for first treatment within 62 days of a referral from a screening service. 8. Performance improved again against the two week wait standards. 9. There was a small improvement in the percentage of people receiving first treatment within 62 days of GP referral. Ten tumour sites contributed breaches, with most in Urological, Lower GI and Gynaecological Oncology. 10. Action continues to be taken to secure additional capacity to treat cancer patients within the national standards and to identify improvements to pathways of care. 11. In September, diagnostic wait performance improved again to 1.73% of patients waiting for over six weeks, though this remained outside the 1% national standard. 12. The national standard for providing care for inpatients with stroke on a dedicated stroke unit was not met for the second month and performance on this worsened. During September, there were also forty-three nationally-reportable breaches of the single-sex accommodation standard. Recommendation 13. The Board is asked to receive the Integrated Performance Report for Month 6. Integrated Performance Report M6 Page 2 of 20

3 Integrated Performance Report: Month 6 (September 20) 1. Key Headlines on Performance 1.1. In September 20, 1,572 patients waited over four hours from arrival to admission, transfer or discharge from OUH s Emergency Departments. The Trust s four-hour wait performance rose 1% to 88.02% During September, no patient waited for over 12 hours in the Emergency Departments from a Decision to Admit (DTA) to admission On 30 September 20, 9,036 of 52,951 patients on incomplete elective care pathways at OUH were waiting for over weeks % of people awaiting elective care were waiting for less than weeks, a reduction of 1% since August and well below the national 92% standard Over 52-week waits in Gynaecology remained stable at 158. Another 41 patients were waiting for over 52 weeks for treatment in 13 other specialties Last-minute cancellations affected 0.65% of elective admissions in September. 5.9% of these patients were not rebooked within 28 days Diagnostic wait performance improved again to 1.73% of patients waiting for over six weeks, though this was still a breach of the 1% national standard Three cancer waiting time standards were not met in September: the standard for 31 day waits to first treatment from a decision to treat; for first treatment within 62 days of urgent GP referral; and for first treatment within 62 days of a referral from a screening service In September: There was one case of MRSA bacteraemia, the second reported in 20/19 (the first having been in August) There were three cases of Clostridium difficile, below the average in the year to date The proportion of births taking place involving Caesarean section or assisted delivery rose above the expected level % of patients with acute stroke spent at least 90% of their time on a stroke unit. OUH moved below the national 85% standard in August (at 84.38%) There were 43 nationally-reportable breaches of the single-sex accommodation standard, taking the year to date total to % of inpatients received a VTE risk assessment in September, maintaining OUH performance above the 95% standard which has been met since December Integrated Performance Report M6 Page 3 of 20

4 2. Urgent Care and Four Hour Waits Performance 2.1. In September 20, 1,572 patients waited over four hours from arrival to admission, transfer or discharge from OUH s Emergency Departments. The Trust s four-hour wait performance rose 1% to 88.02% The Trust s four-hour wait performance was below the trajectory level for the month agreed with NHS Improvement for the second time in 20/ The GP streaming service at the John Radcliffe treated 535 attendances in September, down slightly from 567 in August. Two waited for longer than four hours In September: The number of ED attendances per day rose from 402 to Emergency admissions per day reduced to 199 from 207 in August (and 222 in July) There were (on average) 52.4 breaches of the 4 hour standard per day, compared to 39.7 in June. In September, the trajectory figure would have been met if there had been no more than 43 breaches per day and the 95% national standard would have been met with no more than 21 per day No waits were reported of over 12 hours in OUH s Emergency Departments from a Decision to Admit (DTA) people (12.8 per day) waited 4-12 hours after a DTA Delayed transfers of care affected 51 patients at the end of September 20, down from 61 in August ,755 bed days were used by delayed patients at OUH during the month, down from 2,157 in August Of these bed days, 1,316 (74.9%) involved Oxfordshire residents. Northamptonshire residents accounted for 290 bed days (16.5% of the total, up from 12.9% in August) Overall, 14.99% of these bed days were associated with delays waiting for social care. 61.7% were waits for NHS care. Integrated Performance Report M6 Page 4 of 20

5 Figure 1: OUH Emergency Department attendances, waits and emergency admissions from January % 95% 90% 85% 80% 75% 70% 65% 60% 55% 50% 12hr trolley waits Attendances / day Emergency admissions/day 4-12 hr trolley waits / day >4hr waits / day Performance OUH performance detail 2.9. Emergency Department attendances per week rose in early September after a drop in late July and August. Figure 2: ED attendances, weeks ending 7 January 21 October 20 3,400 3,000 2,600 2, Jan 07-Feb 07-Mar 07-Apr 07-May 07-Jun 07-Jul 07-Aug 07-Sep 07-Oct Emergency admissions reduced markedly in late August but rose again in September. Figure 3: Emergency admissions (all sources), weeks ending 7 January 21 October 20 1,700 1,600 1,500 1,400 1,300 1, Jan 07-Feb 07-Mar 07-Apr 07-May 07-Jun 07-Jul 07-Aug 07-Sep 07-Oct Integrated Performance Report M6 Page 5 of 20

6 2.11. Four-hour wait performance has been above 85% since April but remains in the 85-90% range. Figure 4: Performance against 4 hour standard, OUH, weeks ending 7 January 21 October 20 95% 90% 85% 80% 75% 70% 07-Jan 07-Feb 07-Mar 07-Apr 07-May 07-Jun 07-Jul 07-Aug 07-Sep 07-Oct Breaches of the four hour standard where the person involved was not admitted reduced from a peak in March but rose during September Jan- 08-Feb- 08-Mar- 08-Apr- 08-May- 08-Jun- 08-Jul- 08-Aug- 08-Sep- Figure 5: Non-admitted 4 hour breaches per week, weeks ending 8 January 23 September General and acute bed occupancy (excluding day case, maternity and neonatal beds) has been above 94% since October Having reduced in late May, bed occupancy rose again over the summer, driven by a reduction in available beds. 102% 100% 98% 96% 94% 92% 90% 88% 07-Jan 07-Feb 07-Mar 07-Apr 07-May 07-Jun 07-Jul 07-Aug 07-Sep 07-Oct Figure 6: % bed days occupied, OUH General and Acute beds, after safe staffing bed reductions Progress has continued to be made in reducing the number of bed days occupied by people in OUH beds for over 21 days (termed Super Stranded by NHS Improvement). Since a peak in January of 223 beds being occupied by people with a stay of over 21 days, this total was down 29.15% to 158 in mid-october The number of beds occupied by people staying for over 7 days has also reduced, showing a reduction of 15.7% from 680 on 28 January to 573 on 28 October. Integrated Performance Report M6 Page 6 of 20

7 Beds occupied Oct 13-Oct 06-Oct 29-Sep 22-Sep 15-Sep 08-Sep 01-Sep 25-Aug -Aug 11-Aug 04-Aug 28-Jul 21-Jul Figure 7: Number of patients in OUH beds for >21 days, weekly snapshot, 21 July - 24 October 20 Beds occupied Jan 07-Feb 07-Mar 07-Apr 07-May 07-Jun 07-Jul 07-Aug 07-Sep 07-Oct Figure 8: Number of patients in OUH beds for >7 days, weekly snapshot, 7 January - 28 October The John Radcliffe admitted its first patient of the season with influenza during October. Flu vaccination of staff began in October and progress will be reported in future months. Weekly updates on respiratory illness are published by Public Health England at 20-to-2019-season. As at 31 October, national indications were that flu was below the baseline level expected for hospitalisations but that the Respiratory syncytial virus (RSV) season had begun. RSV usually causes mild respiratory infection in adults and children but can be severe in infants The number of people streamed to GP urgent care alongside the John Radcliffe Emergency Department grew rapidly until May but has since reduced slightly Following a successful pilot, patients already in the Department who are judged suitable for GP care will be streamed to the GP service in November Locum shifts are also being offered to extend the presence of GPs at busy evenings and weekends Oct 13-Oct 06-Oct 29-Sep 22-Sep 15-Sep 08-Sep 01-Sep 25-Aug -Aug 11-Aug 04-Aug 28-Jul 21-Jul Figure 9: Number of people streamed per day to GP urgent care, John Radcliffe, 21 July 25 October 20 Integrated Performance Report M6 Page 7 of 20

8 Key actions 2.5. Key actions in place are: Improving senior clinical decision making in the Emergency Department by reviewing the out of hours rotas; The appointment of a new lead Emergency Department clinician; Reinforcing of internal professional standards and the review of out of hours rotas; Review of bed availability through a reduction in numbers of stranded patients, with a refreshed plan to be agreed by all Divisions and Trust-wide reviews to move to being twice-weekly; A Deputy Director of Urgent Care appointed to support cross-divisional flow, working closely with the new Winter Director and her team. 3. Referral to Treatment Time (RTT) Performance 3.1. On 30 September 20, 9,036 of 52,951 patients on incomplete elective care pathways at OUH were waiting for over weeks % of people awaiting elective care were waiting for less than weeks, a reduction of 1% since August and well below the national 92% standard Over 52-week waits in Gynaecology remained stable at 158. Another 41 patients were waiting for over 52 weeks for treatment in 13 other specialties The total number of people on the Trust s waiting list has stabilised after rapid growth from February 20, but: the number waiting over weeks has continued to grow; the proportion of people on the Incomplete waiting list who are waiting for longer than weeks has risen from 14.3% in May to 17% in September; the Trust s clearance time (equivalent to an average wait ) has risen from weeks in January 20 to weeks in August; and the total list size remains oversized. Analysis of the Trust s list in August 20 1 indicated that it was over 4,700 larger than would make it possible to treat 92% of people on it within weeks. Component waits ,296 people completing RTT Admitted pathways in September 20 were treated within weeks (66.96%). 62 completed treatment after more than 52 weeks. 40 of the 62 were admitted to Gynaecology after more than 52 weeks ,819 patients whose RTT Non-admitted clock stopped in September 20 were within weeks (82.48%). 58 patients on the Non-admitted pathway completed treatment after more than 52 weeks, 32 in Gynaecology. 1 Online analysis by gooroo.co.uk based on data published by NHS England on 11 October 20 Integrated Performance Report M6 Page 8 of 20

9 Specialty waits and long waits 3.7. The total list size in Gynaecology reduced by 9.5% from July to September. The number waiting for a first outpatient appointment reduced in August and September, but 16 people were waiting at the end of September for over 52 weeks for a first appointment, 43 for weeks and a further 308 for -36 weeks. Some clinics continue to have waits of over 44 weeks for a first appointment ,372 people were waiting for over weeks on incomplete Gynaecology pathways on 30 September: 63.4% of waits were within weeks There were 1, week waits in England in November 2017 and 3,306 in August 20. In August, OUH had the second-longest waiting times in Gynaecology in England and 52% of the country s over-52 week waits for Gynaecology Other specialties with over 100 people waiting for over weeks in September on incomplete pathways were as follows: Table 1: Services with >100 > week waits on incomplete pathways, September 20 Treatment function % < Number > Number weeks weeks >52 weeks ENT 61.86% 1,263 1 Gynaecology 63.40% 1, Ophthalmology 80.56% Trauma and Orthopaedics 82.87% Paediatric ENT 53.69% Maxillo Facial Surgery 75.75% Urology 80.70% Dermatology 90.06% Plastic Surgery 72.55% Clinical Genetics 84.48% Spinal Surgery Service 84.25% Paediatric Ophthalmology 64.34% Gastroenterology 91.21% Endoscopy (Gastroenterology) 87.87% Orthodontics 62.89% 1 0 Paediatric Trauma and Orthopaedics 84.41% Neurology 92.70% Vascular Surgery 83.93% Services with over-52 week waits in September were as follows: Table 2: Waits on incomplete RTT pathways of over 52 weeks by treatment function, September 20 Treatment function Number >52 weeks Gynaecology 158 Urology 10 Spinal Surgery Service 6 Integrated Performance Report M6 Page 9 of 20

10 Key actions Treatment function Number >52 weeks Ophthalmology 4 Physiotherapy 4 Trauma and Orthopaedics 3 Colorectal Surgery 3 Interventional Radiology 3 Upper Gastrointestinal Surgery 2 Paediatric Spinal Surgery 2 ENT 1 Maxillo Facial Surgery 1 Vascular Surgery 1 Neurosurgery 1 Total Key actions in place are: Harm review process to review all patients waiting over 52 weeks; Capacity alerts in Gynaecology and ENT which warn patients and GPs of long waits and have started to show some reduction in referrals Weekly monitoring of progress in treating all patients waiting for over 46 weeks, with the intention to move to 40+ week monitoring before Christmas A detailed weekly plan for Gynaecology, with additional surgery for OUH patients being provided by OUH consultants at the Horton Treatment Centre in Banbury, the Manor Hospital in Headington and at the Churchill Hospital Arrangements are being made for an external supplier to provide staff to enable currently-closed operating theatres at the Churchill to be used to treat OUH patients waiting for Urology, General Surgery and Gynaecology The Surgery and Oncology Division making progress on the staffing of a ward and the equipping of operating theatres at the Horton General to enable a wider range of elective urological surgery to be provided there from February, enabling a greater focus at the Churchill on complex and cancer surgery An NHS Improvement-funded data analysis of the Trust s waiting list to review the potential for external waiting list validation to reduce the overall waiting list size by the end of March Diagnostic Waits 4.1. Diagnostic wait performance improved in September to 1.73% of patients waiting for over six weeks, still breaching the 1% national standard In September, a total of 12,338 people waited for diagnostic tests. 213 people waited for over six weeks, down from 290 in August Waits of over six weeks were concentrated in four services: Integrated Performance Report M6 Page 10 of 20

11 MRI, which accounted for 61.03% of all waits over six weeks, with 130 patients waiting over 6 weeks and 11 for over 13 weeks; Colonoscopy, which had 29 waits of over six weeks and one of over 13 weeks; Gastroscopy, with 25 waits of over six weeks and three of over 13; Audiology, with 20 waits of over 6 weeks and none of over Cardiology echocardiography, where previous delays were due to waits for myocardial perfusion scans following a shortage of isotopes which has now been resolved, had no waits of over six weeks in September. 5. Cancer Overall position on national cancer standards 5.1. Three cancer waiting time standards were not met in September: the standard for 96% of patients to receive first definitive treatment within 31 days of a decision to treat; the standard for 62 days to first treatment after urgent GP referral; and the standard for patients to receive their first treatment within 62 days following referral from a screening service Performance improved again against the two week wait standards Performance improved slightly on first treatment within 62 days of GP referral. Over-62 day waits increased in the Urological tumour site group and nine other tumour sites contributed breaches, with most in Lower GI and Gynaecological Oncology Performance by month since May is shown below. The latest published level for England is also shown. Table 3: OUH performance against national cancer standards Standard At least 93% of patients referred from a GP with suspected cancer will be seen within 2 weeks of referral. At least 93% of patients referred from a GP with breast symptoms but not suspected cancer will be seen within 2 weeks of referral. At least 96% of patients will receive first definitive treatment within 31 days of a decision to treat. At least 85% of patients will receive their first treatment within 62 days of referral from a GP. May- OUH performance % England % Jun- Jul- Aug- Sep- Aug Integrated Performance Report M6 Page 11 of 20

12 Standard At least 94% of patients will receive subsequent treatment with surgery within 31 days of decision to treat. At least 98% of patients will receive subsequent treatment with anti-cancer drug regimen within 31 days of decision to treat. At least 94% of patients will receive subsequent radiotherapy within 31 days of a decision to treat. At least 90% of patients will receive their first treatment within 62 days following referral from a screening service. May- OUH performance % England % Jun- Jul- Aug- Sep- Aug % Reporting 5.5. As reported to the Board in paper TB20.27, changes have been made to the system used by NHS England to report on cancer wait standards. This involves being able to report on the 38 day handover date for care responsibility between two providers OUH has been using this new method of reporting (in accordance with the national timetable) since reporting its July waiting time figures. The Trust is finding it difficult to upload data due to the changes made, as are other trusts In early September, an upgrade took place to the Trust s Infoflex cancer information system to the latest version to enable capture of the necessary additional data fields in a timely way The upgraded system is taking time to embed. The reported performance figures for subsequent treatment (with surgery, drugs or radiotherapy) may need to be resubmitted due to some data fields having been found to have required verification after the new system was introduced. Reported performance on these three indicators may worsen. Patients referred from a GP with suspected cancer will be seen within 2 weeks 5.9. This standard was met in September The chart below shows the reduction in waits of longer than two weeks since early summer. The Lower GI and Gynaecological oncology tumour site groups contribute most breaches, with numbers in both reducing since July Urological tumour site waits for first contact have remained low, despite the surge in referrals to the service that took place in early summer. Integrated Performance Report M6 Page 12 of 20

13 Apr- May- Jun- Jul- Aug- Sep- Urological Upper GI Testicular Skin Sarcoma Other Lung Lower GI Head & Neck Haematological Gynaecological Children's Breast Brain CNS Figure 10: Breaches of the two week wait standard by tumour site group from April 20 First definitive treatment within 31 days of a decision to treat Of 271 patients receiving first definitive treatment in September 20, 27 waited for longer than 31 days, performance of 90%. This standard was not met Performance by tumour site is shown below. The impact of growing waits for first urological treatment can be seen Apr- May- Jun- Jul- Aug- Sep- Urological Upper GI Skin Sarcoma Other Lung Lower GI Head & Neck Haematological Gynaecological Children's Figure 11: Breaches by tumour site of the 31 days to first treatment standard from April 20 First treatment within 62 days of a GP referral with suspected cancer In September 20, of referrals for which OUH was accountable, 48 did not receive their first treatment within 62 days of urgent referral from a GP. This was a reduction in breaches and in numbers treated. Performance improved by 2.9% to 71.0% Following an agreed protocol, any cancer patient waiting for over 104 days for treatment has a review conducted of potential for clinical harm from the delay and details are reported to the Clinical Governance Committee. Integrated Performance Report M6 Page 13 of 20

14 5.16. Breaches accountable to OUH by tumour site are shown below. Table 4: People receiving first treatment after 62 days of GP referral with suspected cancer Tumour site group Apr- May- Jun- Jul- Aug- Sep- Breast Gynaecological Haematological Head & Neck Lower GI Lung Other Sarcoma Skin Upper GI Urological All cancers Figure 12 below shows the contribution of Urological breaches since an increase in referrals in early summer. Urological breaches have begun to reduce, but limited treatment capacity means that a raised number is expected until December. Treatment pathways for Gynaecological Oncology, Head and Neck cancer, Lower GI and Lung also remain areas of particular focus. Figure 12: Cancer 62 day breaches by tumour site Urological Upper GI Skin Sarcoma Other Lung Lower GI Head & Neck Haematological Gynaecological Breast Integrated Performance Report M6 Page 14 of 20

15 First treatment within 62 days of screening service referral 5.. This standard was not met in September. Two of patients referred from the breast screening service did not receive first treatment within 62 days and there was one breach in each of the Haematological and Lower Gastrointestinal tumour site groups. Key actions Actions being taken include: Negotiations with providers of temporary clinical staff to support additional theatre lists and staff beds at the Churchill Hospital from November 20 to enable OUH surgeons to operate on patients awaiting cancer surgery NHS Improvement and 20:20 are working with key clinicians in the five particularly challenged tumour sites to carry out redesign and where necessary to make recommendations to improve pathways A revised governance structure and reporting dashboard for OUH cancer services is also being developed. 6. Workforce 6.1. The Trust s vacancy rate in September 20 was 7.8%, down from 8.48% in July but remaining above the Trust s target of 5% At the end of September, there were more whole time equivalent substantive staff in post than in August Sickness absence was 3.19%, just within the Trust s target level of 3.2% The turnover rate was 13.72%, above OUH s 12% target Costs for bank and agency staffing and financial metrics are reported in the Finance Report. 7. Benchmarking 7.1. Shown in the table below is the Trust s position on national key performance indicators for the latest period for which full data are available for the NHS in England and for Shelford Group teaching hospital trusts OUH s 4 hour wait performance in September improved to above the Shelford mean but remained below the national mean. The Trust continued to perform well in August on cancer 2 week waits and waits for subsequent treatment, but performance moved further below these benchmarks on 31 day waits and 62 day waits. RTT performance continued to be below both benchmarks on week and 52 week waits. 2 Cambridge University Hospitals, Central Manchester University Hospitals, Guy s and St Thomas, Imperial College Healthcare, King s College Hospital, Newcastle-Upon-Tyne Hospitals, Oxford University Hospitals, Sheffield Teaching Hospitals, University Hospitals Birmingham and University College London Hospitals. Integrated Performance Report M6 Page 15 of 20

16 Table 5: Key performance indicators for OUH, NHS England and Shelford Group trusts (nationally-published data). Note: NHS England 4 hour performance includes activity provided by non-acute Trusts. Indicator % 4 hour waits from Emergency Department attendance to admission/transfer/discharge <2 week waits to first appointment from urgent GP referral with suspected cancer <2 week waits to first appointment from urgent referral with breast symptoms First treatment within 31 days of cancer diagnosis First cancer treatment within 62 days of urgent referral from screening service First cancer treatment within 62 days of urgent GP referral Subsequent cancer treatment in <31 days: surgery Subsequent cancer treatment in <31 days: drugs Subsequent cancer treatment in <31 days: radiotherapy RTT: >52 week waits, Admitted pathways - Average vs OUH total RTT: >52 week waits, Non-admitted pathways - Average vs OUH total RTT: >52 week waits, Incomplete pathways - Average vs OUH total Standard Data Period England Shelford OUH 95% Sep % 85.48% 88.02% 93% Aug % 92.94% 97.57% 93% Aug % 93.78% 96.21% 96% Aug % 95.34% 94.67% 90% Aug % 87.79% 96.15% 85% Aug % 76.39% 68.06% 94% Aug % 94.76% 100% 98% Aug % 99.32% 100% 94% Aug % 96.43% 98.31% 0 Aug Aug Aug RTT: % < week waits, Admitted pathways 90% Aug % 76.68% 71.05% RTT: % < week waits, Incomplete pathways 92% Aug % 87.83% 83.88% RTT: % < week waits, Non-admitted pathways 95% Aug % 88.70% 84.75% 8. Trajectories 8.1. Waiting list and activity trajectories were sent to NHS Improvement for 20/ The trajectory for four hour waits was met in April-July. The increased trajectory figures for August and September were not met. Table 6: OUH 4 hour wait trajectory 20/19 OUH four hour waits Apr- May- Jun- Jul- Aug- Sep- >4 hour waits - plan 1,890 1,930 1,915 1,890 1,570 1,290 >4 hour waits - actual 1,665 1,581 1,191 1,682 1,616 1,572 Attendances - plan 12,598 14,159 13,919 13,940 12,744 13,002 Attendances - actual 12,149 13,900 13,354 14,173 12,450 13,1 Performance - trajectory 85.0% 86.4% 86.2% 86.4% 87.7% 90.1% Performance - actual 86.30% 88.63% 91.08% 88.13% 87.02% 88.02% Integrated Performance Report M6 Page 16 of 20

17 8.3. The 95% national standard has not been met by the NHS in England or by OUH since July Oxfordshire s NHS met the 90% trajectory figure set for it in Quarter 1 20/19 and in July, but it was not met in August or September. Quarter 2 performance therefore fell below the 90% standard at which 920,000 of Provider Sustainability Funding would have been paid to the Trust by NHS Improvement The basis for calculating eligibility for these payments has been changed to include performance in the year to date. When added together, OUH and Oxford Health s year to date performance was above 90% to the end of Q2. Some corrections have also been made by Oxford Health to their attendance figures which form part of the updated table below. Table 7: Oxfordshire 4 hour wait performance OUH + Oxford Health Jul- Aug- Sep- Q1 Q2 YTD >4 hour waits - actual 1,850 1,672 1,648 4,753 5,170 9,923 Attendances - actual,227 15,808 16,833 50,474 50, ,342 Performance - trajectory 90.0% 90.0% 90.0% 90.0% 90.0% 90.0% Performance - actual 89.85% 89.42% 90.21% 90.58% 89.84% 90.21% 8.6. The trajectory for improvement against the 62 day cancer standard is shown below. Performance since June has been below the expected trajectory. Table 8: Cancer 62 days from urgent GP referral trajectory, 20/19 Cancer 62 days Apr- May- Jun- Jul- Aug- Sep- Waits of >62 days: plan Waits of >62 days: actual Total seen: plan Total seen: actual Performance %: plan 80.0% 79.4% 74.5% 74.2% 75.3% 77.5% Performance %: actual 80.0% 80.2% 72.4% 71.4% 68.1% 71.0% 8.7. For elective care waits (RTT incomplete pathways) in September: Total list size reduced again from its June peak. On 30 September, it was 2,804 above the level it was at on 31 March Completed pathways for admitted and non-admitted care were above plan but the number of people waiting for over weeks grew by 336 (3.9%) The number of over 52 week waits reduced slightly and remained within the expected level. Table 9: RTT trajectories, 20/19 Referral to Treatment: incomplete pathways Number of incomplete RTT pathways <= weeks Number of incomplete RTT pathways > weeks Mar- Apr- May- Jun- Jul- Aug- Sep- Plan 42,560 42,790 42,911 42,832 42,758 42,584 Actual 42,691 44,342 45,102 46,287 46,010 45,276 43,915 Plan 7,464 7,580 7,848 8,265 8,277 8,431 Actual 7,456 7,672 7,555 7,834 8,040 8,700 9,036 Number of incomplete Plan Integrated Performance Report M6 Page 17 of 20

18 Referral to Treatment: incomplete pathways RTT pathways >52 weeks Number of completed admitted RTT pathways Number of completed non-admitted RTT pathways Number of New RTT pathways (clock starts) Mar- Apr- May- Jun- Jul- Aug- Sep- Actual Plan 2,576 2,954 3,053 2,873 2,871 2,893 Actual 3,398 3,593 3,408 3,496 3,475 3,429 Plan 6,649 8,811 8,738 8,884 9,501 9,425 Actual 11,426 12,548 12,138 12,805 11,838 11,904 Plan 16,965 21,159 20,385 20,647 20,240 19,303 Actual 19,717 20,628 20,914 19,901, Additional information 9.1. Quality, Operational and Workforce indicators are shown at Appendix Recommendation The Board is asked to receive the Integrated Performance Report for Month 6. Sara Randall Acting Director of Clinical Services October 20 Integrated Performance Report M6 Page of 20

19 Appendix 1 Quality, Operational and Workforce indicators Data Quality Indicator The data quality rating has 2 components. The first component is a 5 point rating which assesses the level and nature of assurance that is available in relation to a specific set of data. The levels are described in the box below. Rating Required Evidence 1 Standard operating procedures and data definitions are in place. 2 As 1 plus: Staff recording the data have been appropriately trained. 3 As 2 plus: The department/service has undertaken its own audit. 4 As 2 plus: A corporate audit has been undertaken. As 2 plus: An independent audit has been undertaken (e.g. by the Trust's internal or external 5 auditors). The second component of the overall rating is a traffic-light rating to include the level of data quality found through any auditing / benchmarking as below Rating Data Quality Green Satisfactory Amber Data can be relied upon but minor areas for improvement identified. Red Unsatisfactory/significant areas for improvement identified. Quality Standard Current Data Period Period Actual Outcomes Summary Hospital-level Mortality Indicator** NA Mar Total number of deliveries NA Sep Proportion of normal deliveries 62% Sep % 59.8% 5 Proportion of Caesarean section deliveries 23% Sep- 25.3% 24.3% 5 Proportion of assisted deliveries 15% Sep % 15.8% 5 Maternal Deaths NA Sep day emergency readmissions 0% Sep- 3.41% 3.6% 5 Medication reconciliation completed within 24 hours of admission 80% Sep- 69% 71.6% 4 Medication errors causing serious harm 0 Aug Number of CAS alerts closed having breached during the month 0 Sep Dementia CQUIN patients admitted who have had a dementia screen NA Aug % 76.4% 4 Dementia diagnostic assessment and investigation NA Aug- 100% 100% 4 Dementia: Referral for specialist diagnosis NA Aug- 100% 100% 4 Patient Friends & Family test response rate (Inpatients) NA Sep % 21% 4 Experience Friends & Family test response rate (Maternity) NA Sep- 5.17% 8.5% 4 Friends & Family test response rate (Emergency Departments) NA Sep % 23.6% 4 Friends & Family test % not likely to recommend (Emergency Departments) NA Sep- 5.78% 7.6% 4 Friends & Family test % not likely to recommend (Inpatients) NA Sep- 2.3% 2.1% 4 Friends & Family test % not likely to recommend (Maternity) NA Sep- 0.95% 1% 4 Friends & Family test % likely to recommend (Emergency Departments) NA Sep % 87.7% 4 Friends & Family test % likely to recommend (Inpatients) NA Sep- 95.8% 95.8% 4 Friends & Family test % likely to recommend (Maternity) NA Sep % 96.5% 4 Safety Serious Incidents Requiring Investigation NA Sep % of Patients receiving Harm Free Care (Pressure sores, falls, C-UTI and VTE) NA Sep % 92.8% 3 Never Events NA Sep Cleaning Scores: % of inpatient areas with initial score >92% NA Sep % 51.1% 5 % of incidents associated with moderate harm or greater NA Aug- 0.6% 0.7% 5 # newly acquired pressure ulcers (category 2, 3 and 4) NA Aug YTD Data Quality Integrated Performance Report M6 Page 19 of 20

20 Appendix 1 Operational Standard Current Data Period Period Actual Standards RTT: % < week waits, Admitted pathways 90% Sep % 70.7% 4 RTT: % < week waits, Non-admitted pathways 95% Sep % 85.2% 4 RTT: % < week waits, Incomplete pathways 92% Sep % 84.7% 5 % Diagnostic waits waiting 6 weeks or more 1% Sep- 1.73% 2.4% 3 RTT: >52 week waits, Admitted pathways 0 Sep RTT: >52 week waits, Incomplete pathways 0 Sep ,150 4 RTT: >52 week waits, Non-admitted pathways 0 Sep Emergency Department attendances NA Sep- 13,1 79,144 5 % <=4 hour waits from Emergency Department attendance 95% Sep % 88.2% 5 Last minute cancellations: % of elective admissions 0.5% Sep- 0.65% 0.7% 3 % patients not rebooked within 28 days 0% Sep- 5.88% 10.7% 5 Urgent cancellations second time 0 Sep Urgent cancellations 0 Sep Contract Variations Open NA Sep- 16 Contract Notices Open NA Sep- 0 Delayed transfers of care: number (snapshot)* 0 Sep Delayed transfers of care as % of occupied beds* 3.5% Sep- 6.09% 6.2% 5 Theatre utilisation elective 80% Sep- 75.9% 74.6% 4 Theatre utilisation emergency 70% Sep % 48.7% 4 Theatre utilisation total 75% Sep % 67.5% 4 Results endorsed within seven days NA Sep % 74.7% 4 % of discharge summaries sent to GP within 24 hrs 95% Sep- 86.1% 86.1% 4 First cancer treatment within 62 days of urgent GP referral 85% Aug % 74.2% 4 First cancer treatment within 62 days of urgent referral from screening service 90% Aug % 87.4% 4 First treatment within 31 days of cancer diagnosis 96% Aug % 95.3% 4 Subsequent cancer treatment in <31 days: surgery 94% Aug- 100% 94.4% 4 Subsequent cancer treatment in <31 days: drugs 98% Aug- 100% 99% 4 Subsequent cancer treatment in <31 days: radiotherapy 94% Aug % 97.8% 4 <2 week waits to first appointment from urgent GP referral with suspected cancer 93% Aug % 96% 5 <2 week waits to first appointment from urgent referral with breast symptoms 93% Aug % 93.9% 5 Same sex accommodation breaches 0 Sep Patients spending >=90% of time on stroke unit 85% Sep % 89.9% 5 Time to Surgery (% patients having their operation within the time specified according to their clinical categorisation) NA Sep % 92% 3 MRSA bacteraemia 0 Sep Clostridium Difficile incidence 6 Sep % adult inpatients having VTE risk assessment 95% Sep % 97.2% 5 YTD Data Quality Workforce Workforce Performance Target Current Data Period Period Actual Data Quality Vacancy rate 5% Sep- 7.8% 3 Sickness absence** 3.2% Sep- 3.19% 5 Turnover rate 12% Sep % 5 Substantive staff in post against plan 11, Sep- 10, Integrated Performance Report M6 Page 20 of 20

Trust Board Meeting in Public: Wednesday 11 July 2018 TB

Trust Board Meeting in Public: Wednesday 11 July 2018 TB Trust Board Meeting in Public: Wednesday 11 July 2018 Title Integrated Performance Report: Month 2 Status History For information. The report provides a summary of the Trust s performance against a range

More information

RTT Exception Report

RTT Exception Report Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.

More information

Report. Page 113 of 220. NHS South Cheshire CCG and NHS Vale Royal CCG Joint Governing Body. Report To (committee):

Report. Page 113 of 220. NHS South Cheshire CCG and NHS Vale Royal CCG Joint Governing Body. Report To (committee): Report Report To (committee): Report Title: Agenda No.: South Cheshire CCG and Vale Royal CCG Joint Governing Body Performance Report Meeting Date: Thursday 5 th April 2018 Report Author(s) Name/s Andy

More information

Report to Trust Board 26/01/2017. Report Title Operational Performance Report - December 2016 & Quarter /17 Report from

Report to Trust Board 26/01/2017. Report Title Operational Performance Report - December 2016 & Quarter /17 Report from Item 10 Report to Trust Board 26/01/2017 Report Title Operational Performance Report - December 2016 & Quarter 3 2016/17 Report from John Quinn, Director of Operations Prepared by Stephen Chinn, Senior

More information

Ayrshire and Arran NHS Board

Ayrshire and Arran NHS Board Paper 08 Ayrshire and Arran NHS Board Monday 25 November 2013 Waiting Times Report Author: Fraser Doris, Planning and Performance Officer Sponsoring Director: Liz Moore, Director of Acute Services Date:

More information

Operational Performance. SaTH Overall Performance

Operational Performance. SaTH Overall Performance Balanced Scorecard Summary 3 Operational Performance inance Previous This Year to Date Previous This Year to Date Number Number Number Number Number Green 16 17 17 Green 7 7 0 Amber 4 3 3 Amber 0 1 0 Red

More information

NORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report

NORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report NORTHERN HEALTH AND SOCIAL CARE TRUST Waiting Times Summary Report April 2014 1 Waiting Times The Northern Health & Social Care Trust monitors waiting time performance against a number of Departmental

More information

Referral to treatment (RTT) waiting times statistics for consultant-led elective care 2014 Annual Report

Referral to treatment (RTT) waiting times statistics for consultant-led elective care 2014 Annual Report Referral to treatment (RTT) waiting times statistics for consultant-led elective care 2014 Annual Report 1 Referral to treatment (RTT) waiting times statistics for consultant-led elective care 2014 Annual

More information

Long-stay patients methodology Published by NHS England and NHS Improvement

Long-stay patients methodology Published by NHS England and NHS Improvement Long-stay patients methodology Published by NHS England and NHS Improvement July 2018 1 Document Title: Long-stay patients methodology Version number: 1.0 First published: 9 July 2018 Updated: Prepared

More information

Brighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer

Brighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate

More information

DEMAND AND CAPACITY MODELLING

DEMAND AND CAPACITY MODELLING DEMAND AND CAPACITY MODELLING How we used demand and capacity modelling to develop a robust and credible recovery plan Piers Young Deputy Chief Operating Officer (Elective Care) CONTENTS Brief history

More information

Enc 9 Appendix 5 RTT Recovery Plan June 2015 PROGRESS UPDATE MANAGE R LEAD RISKS TO DELIVERY OF ACTION COMPLETION ON DATE NUMBER ACTION EXEC LEAD

Enc 9 Appendix 5 RTT Recovery Plan June 2015 PROGRESS UPDATE MANAGE R LEAD RISKS TO DELIVERY OF ACTION COMPLETION ON DATE NUMBER ACTION EXEC LEAD Enc 9 Appendix 5 RTT Recovery Plan June 2015 Status Key 5 Complete 4 On track 3 Some delay-expect to complete as planned or implemented but not consistently delivering 2 Significant delay unlikely to be

More information

Cancer Improvement Plan Update. September 2014

Cancer Improvement Plan Update. September 2014 Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update

More information

Trust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE

Trust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog

More information

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017 Thursday 14 September 2017 Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017 NHS England released statistics today on referral to treatment (RTT) waiting times for consultant-led

More information

BOARD OF DIRECTORS OPERATIONAL PERFORMANCE REPORT. Month 9 (December 2014) and Quarter 3 (Oct-Dec 14)

BOARD OF DIRECTORS OPERATIONAL PERFORMANCE REPORT. Month 9 (December 2014) and Quarter 3 (Oct-Dec 14) BOARD OF DIRECTORS OPERATIONAL PERFORMANCE REPORT 9 (December 2014) and Quarter 3 (Oct-Dec 14) Presented By: Rob Elek Director of Strategy and Business Development Produced By: Action for Board: For information

More information

Statistical Press Notice NHS referral to treatment (RTT) waiting times data August 2017

Statistical Press Notice NHS referral to treatment (RTT) waiting times data August 2017 Thursday 12 October 2017 Statistical Press Notice NHS referral to treatment (RTT) waiting times data August 2017 NHS England released statistics today on referral to treatment (RTT) waiting times for consultant-led

More information

KPI s September Megan Boivin Operations Manager 15 October KPI s HAC report 18/10/2007 Operations Manager : Megan Boivin

KPI s September Megan Boivin Operations Manager 15 October KPI s HAC report 18/10/2007 Operations Manager : Megan Boivin KPI s September 27 Megan Boivin Operations Manager 15 October 27 KPI s HAC report 18/1/27 Operations Manager : Megan Boivin 63. Dec-6 May-6 Sep-7 KEY PERFORMANCE INDICATORS Month Year to date Month Year

More information

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2018

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2018 Thursday 13 September 2018 Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2018 NHS England released statistics today on referral to treatment (RTT) waiting times for consultant-led

More information

STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA JANUARY 2013

STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA JANUARY 2013 STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA JANUARY 2013 Data are published on consultant-led Referral to Treatment (RTT) waiting times for patients who were treated during

More information

Overseas Vistiors upfront charging tariff 2017/18. James Paget University Hospitals NHS Foundation Trust

Overseas Vistiors upfront charging tariff 2017/18. James Paget University Hospitals NHS Foundation Trust Overseas Vistiors upfront charging tariff 2017/18 James Paget University Hospitals NHS Foundation Trust From 6 April 2015 relevant NHS bodies should only be using the risk-share agreement with commissioners

More information

WELCOME AND INTRODUCTIONS. Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT)

WELCOME AND INTRODUCTIONS. Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) WELCOME AND INTRODUCTIONS Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) ABOUT US OUR COMMUNITY Two main hospital sites King George Hospital

More information

SERVICE TRANSITION PLAN SUMMARY. 1 Jan 2015 IHSS Service Transition Plans (version 8) 1

SERVICE TRANSITION PLAN SUMMARY. 1 Jan 2015 IHSS Service Transition Plans (version 8) 1 SERVICE TRANSITION PLAN SUMMARY 1 IHSS Service Transition Plans (version 8) 1 Summary Service Transition Plan Headlines XXX Target milestone date unknown pendency link Activity period Oct Nov c Jan Feb

More information

Statistical Press Notice NHS referral to treatment (RTT) waiting times data November 2016

Statistical Press Notice NHS referral to treatment (RTT) waiting times data November 2016 Statistical Press Notice NHS referral to treatment (RTT) waiting times data November 2016 NHS England released statistics today on referral to treatment (RTT) waiting times for consultant-led elective

More information

18 WEEK RTT RECOVERY PLAN. April 2015

18 WEEK RTT RECOVERY PLAN. April 2015 18 WEEK RTT RECOVERY PLAN April 2015 1. Background WHHT is not currently compliant with the national RTT standards which require 95% of non-admitted and 90% of admitted patients to receive their elective

More information

NHS Rotherham Clinical Commissioning Group

NHS Rotherham Clinical Commissioning Group NHS Rotherham Clinical Commissioning Group Operational Executive: 2 nd November 2015 Governing Body: 4 th November 2015 Review of Stroke Care Pathway GP Lead: Dr Phil Birks Lead Executive: Keely Firth

More information

Hospital Norovirus Outbreak Reporting

Hospital Norovirus Outbreak Reporting Second Report of the Health Protection Agency. Hospital Norovirus Outbreak Reporting Summary findings In January 2009 the HPA in conjunction with the Infection Prevention Society launched a voluntary National

More information

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic

More information

2010 National Survey. University College London Hospitals NHS Foundation Trust

2010 National Survey. University College London Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories APPENDIX ONE 1 st Appointment (Non-admitted) recovery trajectories The following trajectories show reductions in total waiting list sizes for first appointments. It is difficult for any organisation to

More information

STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA MAY 2011

STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA MAY 2011 STATISTICAL PRESS NOTICE NHS REFERRAL TO TREATMENT (RTT) WAITING TIMES DATA MAY 2011 Main Points Data are published on consultant-led Referral to Treatment (RTT) waiting times for patients who were treated

More information

Cancer Services Position & Recovery Plan June 2015

Cancer Services Position & Recovery Plan June 2015 Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive

More information

Getting It Right First Time. Diabetes Workstream Update

Getting It Right First Time. Diabetes Workstream Update Getting It Right First Time Diabetes Workstream Update Introducing GIRFT 2 Unwarrented Variation 3 GIRFT Regional Hubs The 7 GIRFT Regional Hubs, formed last autumn, will have all gone live by the end

More information

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. East Kent Hospitals University NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department

More information

Evelina London Children s Hospital (ELCH)

Evelina London Children s Hospital (ELCH) Evelina London Children s Hospital (ELCH) Lead Consultant Jenny Handforth PID Pharmacist Faye Chappell Paediatric OPAT CNS Vacant Overview Paediatric OPAT in London Paediatric OPAT ELCH Children s Hospital

More information

Waiting Times for Suspected and Diagnosed Cancer Patients

Waiting Times for Suspected and Diagnosed Cancer Patients Waiting Times for Suspected and Diagnosed Cancer Patients 2015-16 Annual Report Waiting Times for Suspected and Diagnosed Cancer Patients 1 Waiting Times for Suspected and Diagnosed Cancer Patients Prepared

More information

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

Wednesday 29 July Management of Pandemic Flu

Wednesday 29 July Management of Pandemic Flu JOINT TRUST BOARD AND MEMBERSHIP COUNCIL MEETING TITLE Wednesday 29 July 2009 Management of Pandemic Flu PURPOSE To provide a briefing and assurance to the Trust Board and Governors on the actions taken

More information

Paper ref: TB (12/18) 012

Paper ref: TB (12/18) 012 Paper ref: TB (12/18) 12 Report Title Integrated Quality & Performance Report (IQPR) October 218 Sponsoring Executive Toby Lewis, Chief Executive Report Author Dave Baker, Director of Partnerships and

More information

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY

More information

NORTHERN HEALTH AND SOCIAL CARE TRUST

NORTHERN HEALTH AND SOCIAL CARE TRUST NORTHERN HEALTH AND SOCIAL CARE TRUST Trust Corporate Performance Report June 2013 Date Issued: 24/07/13 Contents 1.0 Introduction / Summary 2.0 Commissioner Targets and Associated Activity 3.0 Access

More information

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. South Tees Hospitals NHS Foundation Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey South Tees Hospitals NHS Foundation Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

Mapping inpatient hospital data across England, Scotland and Wales

Mapping inpatient hospital data across England, Scotland and Wales UK Biobank Mapping inpatient hospital data across England, Scotland and Wales Version 1.2 July 2014 http://www.ukbiobank.ac.uk/ Contents Background... 3 Datasets... 3 Mapped data fields... 4 Source of

More information

Quality & Safety Committee Date: 22 June 2016 Agenda item: 4.4

Quality & Safety Committee Date: 22 June 2016 Agenda item: 4.4 SUMMARY REPORT ABM University Health Board Quality & Safety Committee Date: 22 June 20 Agenda item: 4.4 Subject Prepared by Approved by Infection Prevention & Control Delyth Davies, Head of Nursing, Infection

More information

Delirium Avoid it Recognize it Find the cause of it

Delirium Avoid it Recognize it Find the cause of it Delirium Delirium is acute cognitive dysfunction. It has a 20% - 30 day mortality (usually because of underlying conditions). It is associated with increased lengths of hospital stay, increased disability,

More information

Wales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014

Wales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014 Wales Cancer Patient Experience Survey 2013 Aneurin Bevan University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government

More information

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation

More information

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4 GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services

More information

Contract Headlines. OPD headlines 07Jan15

Contract Headlines. OPD headlines 07Jan15 Contract Headlines OPD headlines 07Jan15 Contract Headlines Key issues: ENHT PAH Royal Free HUC Acute In Hours Visiting Service (AIHVS) Contract Headlines Updates: Format / frequency for future updates

More information

PREVIOUS EMPLOYMENT. Associate OT : CJ Occupational Therapy * Assessment and treatment for adults with neurological conditions

PREVIOUS EMPLOYMENT. Associate OT : CJ Occupational Therapy * Assessment and treatment for adults with neurological conditions CURRICULUM VITAE Katie Hanagarth Green Owl Therapy Office 3, 36 Greenhill Street Stratford-upon-Avon CV37 6LE Tel: 01789 413960 / 07966 573317 Email: katie@greenowltherapy.co.uk - Web: www.greenowltherapy.co.uk

More information

EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY

EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY Geriatrics, General practice, Emergency medicine, Interface medicine SUMMARY An integrated, community emergency service specifically designed for

More information

Intelligence supporting Isle of Barra Health Needs Assessment and St. Brendans Hospital Reprovision

Intelligence supporting Isle of Barra Health Needs Assessment and St. Brendans Hospital Reprovision Intelligence supporting Isle of Barra Health Needs Assessment and St. Brendans Hospital Reprovision Public Health Intelligence & Information Services Department Contents 1. Demographics 3 2. St. Brendan

More information

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey Royal National Orthopaedic Hospital NHS Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

Sets out clearly the DoH s expectations of the NHS and the roles and responsibilities of each part of the system over the coming months.

Sets out clearly the DoH s expectations of the NHS and the roles and responsibilities of each part of the system over the coming months. NORTH EAST AMBULANCE SERVICE NHS TRUST UPDATE AND RESILIENCE ACTIONS FOR NHS BOARDS REPORT BY : Director of Ambulance Operations INTRODUCTION As Board members are aware, the World Health Organisation (WHO)

More information

Limitations of the HRG Tariff: The trim point

Limitations of the HRG Tariff: The trim point Limitations of the HRG Tariff: The trim point Dr Rod Jones (ACMA) Statistical Advisor Healthcare Analysis & Forecasting hcaf_rod@yahoo.co.uk For further articles in this series please go to: www.hcaf.biz

More information

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013 Commissioning Cancer Services Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013 The Health & Social Care Bill (27 th March 2012) Two New Organisations NHS Commissioning Board (NHS CB)

More information

We have reviewed the Winter Planning guidance for 2011/12 and have applied the guidance, where relevant, within this refreshed plan.

We have reviewed the Winter Planning guidance for 2011/12 and have applied the guidance, where relevant, within this refreshed plan. NHS National Waiting Times Centre Winter Plan 2011/12 Introduction This plan outlines the proposed action that would be taken to deliver our key business objectives supported by contingency planning. This

More information

TRUST BOARD MEETING - 26 JUNE 2013 Mortality Report. To provide the Trust Board with an update on mortality. Senior Information & Research Analyst

TRUST BOARD MEETING - 26 JUNE 2013 Mortality Report. To provide the Trust Board with an update on mortality. Senior Information & Research Analyst TRUST BOARD MEETING - 26 JUNE 2013 Mortality Report def Agenda Item: 11b PURPOSE PREVIOUSLY CONSIDERED BY Objective(s) to which issue relates * Risk Issues (Quality, safety, financial, HR, legal issues,

More information

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015 What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015 What is Acute Oncology? Outline of Talk Concept of Acute Oncology Service (AOS)

More information

Healthcare Associated Infection Report February 2016 data

Healthcare Associated Infection Report February 2016 data Healthcare Associated Infection Report February 2016 data Section 1 Board Wide Issues Section 1 of the HAIRT covers Board wide infection prevention and control activity and actions. For reports on individual

More information

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations

More information

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance 18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted

More information

Wales Cancer Patient Experience Survey Hywel Dda University Health Board. Published January 2014

Wales Cancer Patient Experience Survey Hywel Dda University Health Board. Published January 2014 Wales Cancer Patient Experience Survey 2013 Hywel Dda University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government

More information

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,

More information

NHS Outcomes Framework: at-a-glance

NHS Outcomes Framework: at-a-glance April 2016 NHS Outcomes Framework: at-a-glance List of outcomes and indicators in the NHS Outcomes Framework for 2016-17 Domain 1: Preventing people from dying prematurely 1a Potential years of life lost

More information

NHS PREPAREDNESS FOR A MAJOR INCIDENT

NHS PREPAREDNESS FOR A MAJOR INCIDENT NHS PREPAREDNESS FOR A MAJOR INCIDENT In light of the recent tragic events in Paris, NHS England has asked that the Trust reviews the following, and that assurance is provided in the form of a Statement

More information

Radiology. General radiology department. X-ray

Radiology. General radiology department. X-ray The radiology directorate provides a diagnostic, interventional and therapeutic service for its local population, and a tertiary service for the region. It also provides support to some national work such

More information

Mid Essex CCG Performance Dashboard September 2013

Mid Essex CCG Performance Dashboard September 2013 Mid Essex CC Dashboard September 2013 MS ugust 0 The CC had 2 cases reported in pril. 0 MS cases in June/July/ugust. Current position Status Update Key Points isk bove ceiling. Please see the Quality eport.

More information

TRUST BOARD SUBMISSION TEMPLATE MEETING Trust Board - Public Ref No. 6.1

TRUST BOARD SUBMISSION TEMPLATE MEETING Trust Board - Public Ref No. 6.1 TRUST BOARD SUBMISSION TEMPLATE MEETING Trust Board - Public Ref No. 6.1 DIRECTOR Interim Director of Planning, Performance and Informatics Date 4 th October 2018 Trust Performance Report Purpose Corporate

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. East Kent Hospitals University NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

Working with you to make Highland the healthy place to be

Working with you to make Highland the healthy place to be Highland NHS Board 2 June 2009 Item 4.3 BREAST CANCER SERVICES COMPLIANCE AGAINST 31 AND 62 DAY TARGETS Report by Derick MacRae, Cancer Service Manager on behalf of Dr Ian Bashford, Medical Director The

More information

Supra Network Sarcoma Advisory Group (SAG) Annual Report

Supra Network Sarcoma Advisory Group (SAG) Annual Report London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer

More information

The European Board of Urology

The European Board of Urology Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal

More information

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL

More information

How to make changes in the NHS

How to make changes in the NHS How to make changes in the NHS Keith Willett Prof of Orthopaedic Trauma Surgery University of Oxford prev. National Clinical Director for Trauma Care ATOCP Conference Oxford 2016 Medical Director for Acute

More information

Supporting and Caring in Dementia

Supporting and Caring in Dementia Supporting and Caring in Dementia Surrey and Sussex Healthcare, Delivering the National Dementia Strategy Strategy and Implementation Plan Final November 2011 1 National Strategy The National Dementia

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

Breast Screening Data Stephen Scott Head of Informatics LCA

Breast Screening Data Stephen Scott Head of Informatics LCA Breast Screening Data Stephen Scott Head of Informatics LCA stephenscott@nhs.net The London Cancer Alliance Overview 62 day screening to 1 st treatment performance Key surgical measures monitored by LCA

More information

Has the UK had a double epidemic?

Has the UK had a double epidemic? Has the UK had a double epidemic? Dr Rodney P Jones Healthcare Analysis & Forecasting www.hcaf.biz hcaf_rod@yahoo.co.uk Introduction Outbreaks of a new type of epidemic, possibly due to immune manipulation,

More information

HealthStat for Hospitals Guide

HealthStat for Hospitals Guide HealthStat for Hospitals Guide 30 JUNE 2010 Version History The table below outlines the changes that have been made to the dashboard and as such this latest version of the HealthStat for Hospitals Guide

More information

Referral to treatment consultant-led waiting times

Referral to treatment consultant-led waiting times Referral to treatment consultant-led waiting times How to Measure DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance

More information

LOOKING BACK FROM THE

LOOKING BACK FROM THE The Clerk s tale EARLY DIAGNOSIS: LOOKING BACK FROM THE ONCOLOGY CLINIC Peter Johnson Professor of Medical Oncology, University of Southampton Chief Clinician, Cancer Research UK A 47 year-old lady Diabetic

More information

Managing and streaming of all admissions The Heartlands experience

Managing and streaming of all admissions The Heartlands experience Managing and streaming of all admissions The Heartlands experience Dr Marwa Mattar, ST6 Acute Medicine Dr Ariyur Balaji, Clinical Lead Acute Medicine BHH Why is this important? Unprecedented demand for

More information

ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW

ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. James Paget University Hospitals NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report Report by the Comptroller and Auditor General HC 82 SesSIon 2009 2010 14 January 2010 Improving Dementia Services in England an Interim Report 4 Summary Improving Dementia Services in England an Interim

More information

TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY

TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY LUCY GROTHIER Director South London Cardiac and Stroke Network lucy.grothier@slcsn.nhs.uk 27 th May 2011 Gaps in London stroke care GAPS

More information

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013

National Cancer Patient Experience Programme. 2012/13 National Survey. Milton Keynes Hospital NHS Foundation Trust. Published August 2013 National Cancer Patient Experience Programme 2012/13 National Survey Published August 2013 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of NHS

More information

One Palliative Care Annual Report

One Palliative Care Annual Report One 203 Palliative Care Annual Report One In 202, ASCO released a provisional clinical opinion stating that concurrent palliative care should be considered early in the course of advanced or metastatic

More information

MEETING OF THE GOVERNING BODY IN PUBLIC

MEETING OF THE GOVERNING BODY IN PUBLIC MEETING OF THE GOVERNING BODY IN PUBLIC 4 th February 2016 Title: Transforming Stroke Services Programme - Next steps to improving stroke services Agenda Item: 15 From: Alison Lathwell, Acting Director

More information

Aligning the Publication of Performance Data Statistics Consultation

Aligning the Publication of Performance Data Statistics Consultation Aligning the Publication of Performance Data Statistics Consultation NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans. & Corp. Ops.

More information

The Single Cancer Pathway

The Single Cancer Pathway The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But

More information

Integrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014

Integrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014 Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative

More information

PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult)

PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult) A03/S(HSS)/a NHS STANDARD CONTRACT FOR PANCREAS TRANSPLANTATION SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION Service Specification No. Service Commissioner Lead Provider

More information

Standard Operating Procedure: Early Intervention in Psychosis Access Times

Standard Operating Procedure: Early Intervention in Psychosis Access Times Corporate Standard Operating Procedure: Early Intervention in Psychosis Access Times Document Control Summary Status: New Version: V1.0 Date: Author/Owner: Rob Abell, Senior Performance Development Manager

More information

Breast Test Wales Screening Division Public Health Wales

Breast Test Wales Screening Division Public Health Wales Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December Breast Test Wales - Quarterly Report October - December Service

More information